Metasphere Labs Inc.
LABZ
CNSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.20K | 1.20K | 174.60K | 672.90K | 1.14M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.20K | 1.20K | 174.60K | 672.90K | 1.14M |
| Cost of Revenue | 1.20K | 1.20K | 40.50K | 132.10K | 188.50K |
| Gross Profit | 100.00 | 100.00 | 134.30K | 540.90K | 950.60K |
| SG&A Expenses | 453.70K | 562.50K | 711.80K | 811.70K | 804.30K |
| Depreciation & Amortization | -- | -- | 32.70K | 62.70K | 67.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 468.80K | 593.00K | 820.50K | 1.04M | 1.10M |
| Operating Income | -467.40K | -591.60K | -645.80K | -369.00K | 43.50K |
| Income Before Tax | -517.90K | -655.40K | -1.20M | -892.50K | -439.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.52 | -0.66 | -1.20 | -0.89 | -0.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -517.90K | -655.40K | -1.20M | -892.50K | -439.50K |
| EBIT | -467.40K | -591.60K | -645.80K | -369.00K | 43.50K |
| EBITDA | -380.70K | -573.80K | -627.90K | -325.60K | 87.20K |
| EPS Basic | -0.05 | -0.07 | -0.14 | -0.11 | -0.02 |
| Normalized Basic EPS | -0.03 | -0.04 | -0.05 | -0.03 | 0.02 |
| EPS Diluted | -0.06 | -0.08 | -0.16 | -0.12 | -0.05 |
| Normalized Diluted EPS | -0.03 | -0.04 | -0.05 | -0.03 | -0.01 |
| Average Basic Shares Outstanding | 41.73M | 40.24M | 37.37M | 37.45M | 31.25M |
| Average Diluted Shares Outstanding | 41.73M | 40.24M | 37.37M | 41.52M | 38.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |